BIND Therapeutics Announces Collaboration with Affilogic to Provide BIND with Access to Targeting Ligands that are Key Modulators of Anti-tumor Immunity

World News: . []

BIND Therapeutics Inc NASDAQ BIND a biotechnology company developing LINK  and programmable therapeutics called ACCURINS today LINK  a research collaboration with Affilogic a LINK  held biotechnology company...

More news and information about BIND Therapeutics, Inc.

Published By:

Business Wire: 13:00 GMT Thursday 5th May 2016

Published: .

Search for other references to "bind" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us